DrugPatentWatch Database Preview

Details for Patent: 9,089,528

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,089,528 protect, and when does it expire?

Patent 9,089,528 protects PHOSLYRA and is included in one NDA.

This patent has twenty-four patent family members in seventeen countries.

Summary for Patent: 9,089,528

Title:	Liquid compositions of calcium acetate
Abstract:	The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.
Inventor(s):	Tarallo; Stephen C. (Brockton, MA)
Assignee:	LYNE LABORATORIES, INC. (Brockton, MA)
Application Number:	14/053,126
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 9,089,528

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fresenius Medcl	PHOSLYRA	calcium acetate	SOLUTION;ORAL	022581-001	Apr 18, 2011		RX	Yes	Yes						USE OF PHOSLYRA FOR REDUCTION OF SERUM PHOSPHOROUS IN PATIENTS

International Family Members for US Patent 9,089,528

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	547099
Australia	2007275606
Brazil	PI0714882
Canada	2658465